automated-news
When an electric vehicle startup posts its first-ever profit after years of losses and sees its stock surge 28% in a day, comparisons to Tesla become inevitable. Rivian just had that moment. But scratch beneath the surface, and you'll find a company racing against a ticking clock while
automated-news
Was it worth the investment, or was this merely a $500+ nice-to-have gadget? I decided to put it to the test. Read Full Article →
automated-news
Was it worth the investment, or was this merely a $500+ nice-to-have gadget? I decided to put it to the test. Read Full Article →
automated-news
Jammu and Kashmir Police busted a major digital investment scam in Ganderbal, seizing 250 accounts linked to ₹209 crore in verified transactions and arresting the mastermind, Dr. Morphine. A Special Investigation Team is tracing the money trail across India and abroad, while authorities plan to attach properties and issue notices
automated-news
Ferrari NV announced that it purchased 30,293 of its own shares between February 9 and 13, at a price of EUR304.8845 each, for a total value of EUR9.2 million. Following the buyback, the company... Read Full Article →
automated-news
The health and beauty chain’s private equity owner is looking at expansion before a possible stock market flotation Read Full Article →
automated-news
Fortis Healthcare Limited has issued a postal ballot notice seeking shareholder approval for its Employee Stock Option Scheme 2026, covering up to 1,50,99,163 stock options representing 2% of outstanding share capital. The scheme targets eligible employees across the company, subsidiaries, and associates with vesting periods ranging from
/Paychex%20Inc_%20office-by%20Eric%20Glenn%20via%20Shutterstock.jpg)
automated-news
As Paychex has underperformed relative to the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects. Read Full Article →
automated-news
Prabhat Technologies (India) Limited has postponed its board meeting from February 16, 2026 to February 18, 2026 due to unavoidable reasons. The rescheduled meeting will focus on discussing unaudited financial results for the quarter and nine months ended December 31, 2025. The company has maintained its trading window closure until
automated-news
Eli Lilly and Company announced positive topline results from the Phase 3 LIBRETTO-432 clinical trial of Retevmo as adjuvant therapy versus placebo. The study met its primary endpoint, demonstrating... Read Full Article →
automated-news
Joel Klatt publicly cheered on MrBeast’s $100 million football investment idea, framing it as a potential catalyst for the G5 program. Read Full Article →
automated-news
Tech News News: Capgemini CEO Aiman Ezzat has warned business leaders against racing too far ahead on AI adoption. He said that companies risk investing in capabiliti. Read Full Article →